| Literature DB >> 33987117 |
Mickaël Chouk1, Alexandre Halb2, Christine Mekhail1, Amélie Godot3, Frank Verhoeven1, Clément Prati1, Daniel Wendling1.
Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized mainly by arthritis, with the possible occurrence of extra-articular manifestations. We report the case of a patient who developed leptomeningitis as the first sign of RA, one year before the diagnosis of RA. Methylprednisolone 1000 mg was given intravenously. Because of the onset of seizures and cognitive impairment, rituximab was started. After three cycles of rituximab (1000 mg on day 0 and 1000 mg on day 15, every 6 months), neurological clinical examination, MRI and electroencephalogram findings were significantly improved. LEARNING POINTS: Rheumatoid meningitis may occur in the disease course of rheumatoid arthritis with varied and non-specific symptoms.Cerebrospinal fluid examination, MRI and tests for rheumatoid factor or anti-citrullinated protein antibodies in serum or in cerebrospinal fluid are key examinations for diagnosing rheumatoid meningitis.Rituximab has good efficacy in rheumatoid meningitis. © EFIM 2021.Entities:
Keywords: Rheumatoid arthritis; leptomeningitis; rheumatoid meningitis; rituximab; seizure
Year: 2021 PMID: 33987117 PMCID: PMC8112082 DOI: 10.12890/2021_002358
Source DB: PubMed Journal: Eur J Case Rep Intern Med ISSN: 2284-2594